Literature DB >> 20044645

Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan.

Hwei-Chung Wang1, Chiu-Shong Liu, Chang-Fang Chiu, Su-Yin Chiang, Chung-Hsing Wang, Rou-Fen Wang, Cheng-Chieh Lin, Ru-Yin Tsai, Da-Tian Bau.   

Abstract

AIM: To evaluate the association between the genotypes of the heterodimeric DNA-binding component, Ku80 gene and the breast cancer risk in Taiwan. PATIENTS AND METHODS: In this hospital-based case-control study, the association of Ku80 G-1401T rs828907, Ku80 C-319T rs11685387 and Ku80 intron19 rs9288518 polymorphisms with breast cancer risk in a Taiwanese population was investigated. In total, 1272 patients with breast cancer and the same number of age- and gender-matched healthy controls were genotyped.
RESULTS: A significantly different distribution was found in the frequency of the Ku80 G-1401T genotype, but not the Ku80 C-319T or intron 19 genotypes, between the breast cancer and control groups. The T allele Ku80 G-1401T conferred a significant (p=0.0069) increased risk of breast cancer. Gene interactions with smoking, but not with breastfeeding, were significant for the Ku80 G-1401T polymorphism. The Ku80 G-1401T GT and TT genotypes in association with smoking conferred an increased risk of 3.162 (95% confidence interval=2.275-4.393) for breast cancer.
CONCLUSION: The T allele of Ku80 G-1401T may be associated with the development of breast cancer and may be a novel useful marker for breast cancer detection and prediction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044645

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The Ku70 -1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population.

Authors:  Wenshan He; Sijia Luo; Tao Huang; Jinghua Ren; Xiaoling Wu; Jun Shao; Qingyao Zhu
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

2.  XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor.

Authors:  Kaiwu Xu; Xinming Song; Zhihui Chen; Changjiang Qin; Yulong He
Journal:  Oncol Lett       Date:  2014-06-11       Impact factor: 2.967

3.  The current progress and future prospects of personalized radiogenomic cancer study.

Authors:  Juhn-Cherng Liu; Wu-Chung Shen; Tzu-Ching Shih; Chia-Wen Tsai; Wen-Shin Chang; Der-Yang Cho; Chang-Hai Tsai; Da-Tian Bau
Journal:  Biomedicine (Taipei)       Date:  2015-02-02

4.  The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple negative breast cancer risk.

Authors:  Wen-Shin Chang; Liang-Chih Liu; Chieh-Lun Hsiao; Chen-Hsien Su; Hwei-Chung Wang; Hong-Xue Ji; Chia-Wen Tsai; Ming-Chei Maa; Da-Tian Bau
Journal:  Biomedicine (Taipei)       Date:  2016-02-10

Review 5.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.

Authors:  Brock J Sishc; Anthony J Davis
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

6.  Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells.

Authors:  Bin Shang; Yang Jia; Gang Chen; Zhou Wang
Journal:  Respir Res       Date:  2017-04-11

7.  Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance.

Authors:  Qingshan Ma; Ping Li; Minyu Xu; Jinzhi Yin; Zhenzhong Su; Wei Li; Jie Zhang
Journal:  J Exp Clin Cancer Res       Date:  2012-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.